Cargando…

Spirometry in Greenland: a cross-sectional study on patients treated with medication targeting obstructive pulmonary disease

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is globally increasing in frequency and is expected to be the third largest cause of death by 2020. Smoking is the main risk factor of developing COPD. In Greenland, more than half of the adult population are daily smokers, and COPD may be com...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Lasse Overballe, Olsen, Sequssuna, Jarbøl, Dorte Ejg, Pedersen, Michael Lynge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148803/
https://www.ncbi.nlm.nih.gov/pubmed/27938634
http://dx.doi.org/10.3402/ijch.v75.33258
_version_ 1782473884265611264
author Nielsen, Lasse Overballe
Olsen, Sequssuna
Jarbøl, Dorte Ejg
Pedersen, Michael Lynge
author_facet Nielsen, Lasse Overballe
Olsen, Sequssuna
Jarbøl, Dorte Ejg
Pedersen, Michael Lynge
author_sort Nielsen, Lasse Overballe
collection PubMed
description BACKGROUND: Chronic obstructive pulmonary disease (COPD) is globally increasing in frequency and is expected to be the third largest cause of death by 2020. Smoking is the main risk factor of developing COPD. In Greenland, more than half of the adult population are daily smokers, and COPD may be common. International guidelines recommend the usage of spirometry as a golden standard for diagnosing COPD. The current number of spirometries performed among patients treated with medication targeting obstructive pulmonary disease in Greenland remains unexplored. OBJECTIVE: To estimate the prevalence of patients aged 50 years or above treated with medication targeting obstructive pulmonary disease and the extent to which spirometry was performed among them within 2 years. DESIGN: An observational, cross-sectional study based on the review of data obtained from electronic medical records in Greenland was performed. The inclusion criterion was that patients must have been permanent residents aged 50 years or above who had medication targeting obstructive pulmonary disease prescribed within a period of 15 months prior to data extraction. A full review of electronic patient records was done on each of the identified users of medication targeting obstructive pulmonary disease. Information on age, gender, town and spirometry was registered for each patient within the period from October 2013 to October 2015. RESULTS: The prevalence of patients treated with medication targeting obstructive pulmonary disease aged 50 years or above was 7.9%. Of those, 34.8% had spirometry performed within 2 years and 50% had a forced expiratory volume (1 sec)/ forced vital capacity (FEV1/FVC) under 70% indicating obstructive pulmonary disease. CONCLUSION: The use of medication targeting obstructive pulmonary disease among patients over 50 years old is common in Greenland. About one third of the patients had a spirometry performed within 2 years. To further increase spirometry performance, it is recommended to explore possible barriers in health care professionals’ usage of spirometry in different health care settings in Greenland.
format Online
Article
Text
id pubmed-5148803
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Co-Action Publishing
record_format MEDLINE/PubMed
spelling pubmed-51488032016-12-21 Spirometry in Greenland: a cross-sectional study on patients treated with medication targeting obstructive pulmonary disease Nielsen, Lasse Overballe Olsen, Sequssuna Jarbøl, Dorte Ejg Pedersen, Michael Lynge Int J Circumpolar Health Original Research Article BACKGROUND: Chronic obstructive pulmonary disease (COPD) is globally increasing in frequency and is expected to be the third largest cause of death by 2020. Smoking is the main risk factor of developing COPD. In Greenland, more than half of the adult population are daily smokers, and COPD may be common. International guidelines recommend the usage of spirometry as a golden standard for diagnosing COPD. The current number of spirometries performed among patients treated with medication targeting obstructive pulmonary disease in Greenland remains unexplored. OBJECTIVE: To estimate the prevalence of patients aged 50 years or above treated with medication targeting obstructive pulmonary disease and the extent to which spirometry was performed among them within 2 years. DESIGN: An observational, cross-sectional study based on the review of data obtained from electronic medical records in Greenland was performed. The inclusion criterion was that patients must have been permanent residents aged 50 years or above who had medication targeting obstructive pulmonary disease prescribed within a period of 15 months prior to data extraction. A full review of electronic patient records was done on each of the identified users of medication targeting obstructive pulmonary disease. Information on age, gender, town and spirometry was registered for each patient within the period from October 2013 to October 2015. RESULTS: The prevalence of patients treated with medication targeting obstructive pulmonary disease aged 50 years or above was 7.9%. Of those, 34.8% had spirometry performed within 2 years and 50% had a forced expiratory volume (1 sec)/ forced vital capacity (FEV1/FVC) under 70% indicating obstructive pulmonary disease. CONCLUSION: The use of medication targeting obstructive pulmonary disease among patients over 50 years old is common in Greenland. About one third of the patients had a spirometry performed within 2 years. To further increase spirometry performance, it is recommended to explore possible barriers in health care professionals’ usage of spirometry in different health care settings in Greenland. Co-Action Publishing 2016-12-08 /pmc/articles/PMC5148803/ /pubmed/27938634 http://dx.doi.org/10.3402/ijch.v75.33258 Text en © 2016 Lasse Overballe Nielsen et al. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for any purpose, even commercially, provided the original work is properly cited and states its license.
spellingShingle Original Research Article
Nielsen, Lasse Overballe
Olsen, Sequssuna
Jarbøl, Dorte Ejg
Pedersen, Michael Lynge
Spirometry in Greenland: a cross-sectional study on patients treated with medication targeting obstructive pulmonary disease
title Spirometry in Greenland: a cross-sectional study on patients treated with medication targeting obstructive pulmonary disease
title_full Spirometry in Greenland: a cross-sectional study on patients treated with medication targeting obstructive pulmonary disease
title_fullStr Spirometry in Greenland: a cross-sectional study on patients treated with medication targeting obstructive pulmonary disease
title_full_unstemmed Spirometry in Greenland: a cross-sectional study on patients treated with medication targeting obstructive pulmonary disease
title_short Spirometry in Greenland: a cross-sectional study on patients treated with medication targeting obstructive pulmonary disease
title_sort spirometry in greenland: a cross-sectional study on patients treated with medication targeting obstructive pulmonary disease
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148803/
https://www.ncbi.nlm.nih.gov/pubmed/27938634
http://dx.doi.org/10.3402/ijch.v75.33258
work_keys_str_mv AT nielsenlasseoverballe spirometryingreenlandacrosssectionalstudyonpatientstreatedwithmedicationtargetingobstructivepulmonarydisease
AT olsensequssuna spirometryingreenlandacrosssectionalstudyonpatientstreatedwithmedicationtargetingobstructivepulmonarydisease
AT jarbøldorteejg spirometryingreenlandacrosssectionalstudyonpatientstreatedwithmedicationtargetingobstructivepulmonarydisease
AT pedersenmichaellynge spirometryingreenlandacrosssectionalstudyonpatientstreatedwithmedicationtargetingobstructivepulmonarydisease